Hiroe Ogawa

464 total citations
16 papers, 360 citations indexed

About

Hiroe Ogawa is a scholar working on Rheumatology, Nephrology and Hematology. According to data from OpenAlex, Hiroe Ogawa has authored 16 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 4 papers in Nephrology and 4 papers in Hematology. Recurrent topics in Hiroe Ogawa's work include Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Renal Diseases and Glomerulopathies (4 papers). Hiroe Ogawa is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Renal Diseases and Glomerulopathies (4 papers). Hiroe Ogawa collaborates with scholars based in Japan. Hiroe Ogawa's co-authors include Koichi Amano, Hayato Nagasawa, Hirofumi Takei, Hideto Kameda, Tsutomu Takeuchi, Naoya Sekiguchi, Michihide Tokuhira, Kensei Tsuzaka, Katsuya Suzuki and Takahiko Kurasawa and has published in prestigious journals such as Rheumatology International, Modern Rheumatology and Internal Medicine.

In The Last Decade

Hiroe Ogawa

16 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroe Ogawa Japan	10	262	223	101	44	44	16	360
Hirofumi Takei Japan	13	365 1.4×	225 1.0×	207 2.0×	89 2.0×	58 1.3×	23	539
O. Vicari Italy	5	162 0.6×	264 1.2×	42 0.4×	72 1.6×	42 1.0×	6	522
M. Vilardell-Tarrés Spain	9	272 1.0×	73 0.3×	95 0.9×	27 0.6×	27 0.6×	11	386
P. Palla Italy	5	223 0.9×	251 1.1×	36 0.4×	104 2.4×	56 1.3×	6	586
Jonathan Dunham United States	8	226 0.9×	115 0.5×	75 0.7×	53 1.2×	63 1.4×	9	447
Reika Maezawa Japan	12	248 0.9×	356 1.6×	162 1.6×	19 0.4×	66 1.5×	28	512
H. Fernández‐Llaca Spain	10	166 0.6×	100 0.4×	181 1.8×	31 0.7×	54 1.2×	19	438
Xavier Solanich Spain	9	127 0.5×	162 0.7×	115 1.1×	19 0.4×	24 0.5×	37	384
Olcay Aydıntuğ Türkiye	11	231 0.9×	108 0.5×	73 0.7×	13 0.3×	30 0.7×	20	426
C. Mata Spain	10	111 0.4×	68 0.3×	126 1.2×	50 1.1×	23 0.5×	14	291

Countries citing papers authored by Hiroe Ogawa

Since Specialization

Citations

This map shows the geographic impact of Hiroe Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroe Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroe Ogawa more than expected).

Fields of papers citing papers by Hiroe Ogawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroe Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroe Ogawa. The network helps show where Hiroe Ogawa may publish in the future.

Co-authorship network of co-authors of Hiroe Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroe Ogawa. A scholar is included among the top collaborators of Hiroe Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroe Ogawa. Hiroe Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Kameda, Hideto, Hiroe Ogawa, Hayato Nagasawa, et al.. (2013). Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis. Modern Rheumatology. 23(1). 97–103. 8 indexed citations

2.

Kurasawa, Takahiko, Hayato Nagasawa, Hirofumi Takei, et al.. (2013). Successful Treatment of Class IV+V Lupus Nephritis with Combination Therapy of High-dose Corticosteroids, Tacrolimus and Intravenous Cyclophosphamide. Internal Medicine. 52(10). 1125–1130. 5 indexed citations

3.

Kameda, Hideto, Hiroe Ogawa, Hayato Nagasawa, et al.. (2012). Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis. Modern Rheumatology. 23(1). 97–103. 10 indexed citations

4.

Takei, Hirofumi, Hayato Nagasawa, Ryota Sakai, et al.. (2012). A Case of Multiple Giant Coronary Aneurysms and Abdominal Aortic Aneurysm Coexisting with IgG4-related Disease. Internal Medicine. 51(8). 963–967. 25 indexed citations

5.

Suzuki, Katsuya, Hideto Kameda, Koichi Amano, et al.. (2009). Single center prospective study of tacrolimus efficacy and safety in treatment of rheumatoid arthritis. Rheumatology International. 29(4). 431–436. 16 indexed citations

6.

Kameda, Hideto, Koichi Amano, Hayato Nagasawa, et al.. (2009). Notable Difference between the Development of Vertebral Fracture and Osteonecrosis of the Femoral Head in Patients Treated with High-dose Glucocorticoids for Systemic Rheumatic Diseases. Internal Medicine. 48(22). 1931–1938. 6 indexed citations

7.

Ogawa, Hiroe, Hideto Kameda, Hayato Nagasawa, et al.. (2007). Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis. Modern Rheumatology. 17(2). 92–97. 20 indexed citations

8.

Ogawa, Hiroe, Hideto Kameda, Hayato Nagasawa, et al.. (2007). Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis. Modern Rheumatology. 17(2). 92–97. 14 indexed citations

9.

Kameda, Hideto, Naoya Sekiguchi, Hayato Nagasawa, et al.. (2006). Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab. Modern Rheumatology. 16(6). 381–388. 12 indexed citations

10.

Kameda, Hideto, Naoya Sekiguchi, Hayato Nagasawa, et al.. (2006). Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab. Modern Rheumatology. 16(6). 381–388. 12 indexed citations

11.

Kameda, Hideto, Hayato Nagasawa, Hiroe Ogawa, et al.. (2005). Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.. PubMed. 32(9). 1719–26. 178 indexed citations

12.

Ogawa, Hiroe, et al.. (2005). Manifestations mimicking relapsing polychondritis in a patient with microscopic polyangiitis.. Japanese Journal of Clinical Immunology. 28(2). 104–108. 2 indexed citations

13.

Mori, Takehiko, Hideto Kameda, Hiroe Ogawa, et al.. (2004). Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy.. PubMed. 31(7). 1349–51. 33 indexed citations

14.

Kameda, Hideto, Koichi Amano, Naoya Sekiguchi, et al.. (2004). Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis: a better response in male patients. Modern Rheumatology. 14(6). 442–446. 15 indexed citations

15.

Kameda, Hideto, Koichi Amano, Naoya Sekiguchi, et al.. (2004). Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis: a better response in male patients. Modern Rheumatology. 14(6). 442–446. 2 indexed citations

16.

Yoshida, Mari, et al.. (1989). Influence of abnormal occlusion in the analysis of chewing movement. 7. 31–44. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact